Synthetic Biologics, Inc. (SYN)
Stock-Based Compensation
$651.00K
TTM · Period ending: · USD
SYN Stock-Based Compensation
Latest reported$651.00Kperiod ending
Latest reported$651.00Kperiod ending
SYN TTM Stock-Based Comp ($0.00 → $651.00K)
TTM stock-based compensation
High-resolution chart · PNG
SYN stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 651,000 | |
| 689,000 | |
| 654,000 | |
| 794,000 | |
| 692,000 | |
| 658,000 | |
| 671,000 | |
| 490,000 | |
| 475,000 | |
| 438,000 | |
| 427,000 | |
| 416,000 | |
| 404,000 | |
| 384,000 | |
| 368,000 | |
| 350,000 | |
| 345,000 | |
| 354,000 | |
| 359,000 | |
| 340,000 | |
| 612,000 | |
| 996,000 | |
| 1,462,000 | |
| 2,074,000 | |
| 2,211,000 | |
| 2,636,000 | |
| 2,950,000 | |
| 3,409,000 | |
| 4,009,000 | |
| 4,056,000 | |
| 4,092,000 | |
| 4,009,000 | |
| 4,045,000 | |
| 3,744,000 | |
| 3,423,000 | |
| 3,198,000 | |
| 2,691,000 | |
| 2,655,000 | |
| 2,924,000 | |
| 2,459,000 | |
| 2,294,000 | |
| 2,022,000 | |
| 1,574,000 | |
| 1,669,000 | |
| 1,750,000 | |
| 1,807,000 | |
| 1,800,000 | |
| 1,851,000 | |
| 1,810,866 | |
| 1,578,724 | |
| 1,236,089 | |
| 1,232,000 | |
| 1,013,285 | |
| 938,738 | |
| 978,933 | |
| 660,649 | |
| 450,894 | |
| 416,880 | |
| 418,019 | |
| 323,936 | |
| 1,469,515 | |
| 1,415,218 | |
| 1,316,519 | |
| 1,605,619 | |
| 1,863,767 | |
| 1,863,767 | |
| 1,863,767 | |
| 1,483,123 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |